Acute Effects of AMPS on Cardiovascular, Functional Capacity and Postural Control in Patients With Parkinson's Disease
NCT ID: NCT05456282
Last Updated: 2022-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2019-12-01
2023-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is that one single session will be effective in improving, acutely, the cardiovascular system and functional capacity in patients with PD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of AMPS on Cardiovascular Variables in Patients With Parkinson's Disease
NCT04251728
Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation
NCT02594540
Assessment of Transcranial Electrical Stimulation and Auditory Stimulation During Walking in Parkinson Patients
NCT05264909
Effect of WB-EMS on Parkinson's Disease
NCT04878679
Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease
NCT05421624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AMPS first, then SHAM
Participants will receive first one session of automated mechanical peripheral stimulation (AMPS) with intensity at the pain threshold. Then, after a 2-week washout, they will receive one session of a simulated automated mechanical peripheral stimulation (SHAM) with intensity at the sensory threshold.
Automated mechanical peripheral stimulation
Automated mechanical pressure reaching the pain threshold in four specific points at the foots soles
SHAM
Automated mechanical pressure reaching the sensory threshold in four specific points at the foots soles
SHAM first, then AMPS
Participants will receive first one session of simulated automated mechanical peripheral stimulation (SHAM) with intensity at the sensory threshold. Then, after a 2-week washout, they will receive one session of automated mechanical peripheral stimulation (AMPS) with intensity at the pain threshold.
Automated mechanical peripheral stimulation
Automated mechanical pressure reaching the pain threshold in four specific points at the foots soles
SHAM
Automated mechanical pressure reaching the sensory threshold in four specific points at the foots soles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Automated mechanical peripheral stimulation
Automated mechanical pressure reaching the pain threshold in four specific points at the foots soles
SHAM
Automated mechanical pressure reaching the sensory threshold in four specific points at the foots soles
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scoring 1 to 3 on the Hoehn and Yhar scale
* Pharmacological treatment unchanged for at least 30 days prior the study
Exclusion Criteria
* Cardiorespiratory, neuromuscular and musculoskeletal diseases not related to PD
* Sensory peripheral neuropathy, diabetes or any other disease known to promote autonomic dysfunction
30 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica del Maule
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Roberto Zamunér
Adjunct Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio R Zamunér, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Católica del Maule
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Católica del Maule - Campus San Miguel
Talca, Maule Region, Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Carolina Toloza
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11180310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.